Injectable profiloplasty: Forehead, nose, lips, and chin filler treatment.


Journal

Journal of cosmetic dermatology
ISSN: 1473-2165
Titre abrégé: J Cosmet Dermatol
Pays: England
ID NLM: 101130964

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 24 07 2018
accepted: 05 09 2018
pubmed: 18 11 2018
medline: 18 12 2019
entrez: 17 11 2018
Statut: ppublish

Résumé

We propose a medical filler treatment algorithm of the profile which includes forehead, nose, and chin and to evaluate profilometric results and complications. 83 case reviews of associated liquid forehead, nose, and chin plasty performed consecutively from 2014 to 2016. We monitored the horizontal and vertical sagittal stability into two age group: <40 y.o. and >40 y.o. using profilometric Arnett analysis measurements on the F, Gb, Na, Nd, Nt, Sn, ULA, LLA, B, Pg, and Gn soft-tissue points. The results at both 3 and 6 months were consistent with the normal ranges indicated by Arnett, with a 0.8 mm maximum of defect/excess. Forehead treatment was performed in 51 (61.4%) patient. Patients >40 y.o. always needed a global correction of the forehead profile. We performed nasal treatment in 83 (100%) patient, acute nasolabial angles was the more frequent nasal defect. The lips were injected in 59 patients (71.1) more frequently >40 y.o. In 83 (100%) patients we perform a chin augmentation. The average advancement of the chin was 3 mm. The correction of the projection of the forehead, of the profile and shape of the nose, of the lips and chin as well as an overall improvement in face aesthetics and harmony gives a good solution in patients avoiding the need for a surgical intervention, scars and cost of general anesthesia, thus providing the optimum in patient satisfaction.

Identifiants

pubmed: 30444074
doi: 10.1111/jocd.12792
doi:

Substances chimiques

Dermal Fillers 0
Deoxycholic Acid 005990WHZZ
Hyaluronic Acid 9004-61-9

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

976-984

Subventions

Organisme : Allergan SpA

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Auteurs

Dario Bertossi (D)

Maxillofacial Surgery, G.B. Rossi Hospital and Medical University of Verona, Piazzale, L.A. Scuro 10, 37134, Verona, Italy.

Luca Lanaro (L)

Maxillofacial Surgery, G.B. Rossi Hospital and Medical University of Verona, Piazzale, L.A. Scuro 10, 37134, Verona, Italy.

Irene Dell'Acqua (I)

Maxillofacial Surgery, G.B. Rossi Hospital and Medical University of Verona, Piazzale, L.A. Scuro 10, 37134, Verona, Italy.

Massimo Albanese (M)

Maxillofacial Surgery, G.B. Rossi Hospital and Medical University of Verona, Piazzale, L.A. Scuro 10, 37134, Verona, Italy.

Luciano Malchiodi (L)

Oral Surgery, G.B. Rossi Hospital and Medical University of Verona, Piazzale L.A. Scuro 10, 37134, Verona, Italy.

Pier Francesco Nocini (PF)

Division of Dental and Maxillofacial Surgery, G.B. Rossi Hospital and Medical University of Verona, Piazzale L.A. Scuro 10, 37134, Verona, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH